2023-509929-51-00招募中1 期
Single and multiple ascending dose of ZP9830 in healthy participants
Zealand Pharma A/S1 个研究点 分布在 1 个国家目标入组 92 人开始时间: 2024年10月28日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 92
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Trial Information Desk
Scientific
Zealand Pharma A/S
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A Study to Investigate Single Ascending Doses of Ocrelizumab for Safety and Side Effects, How The Body Handles It Over A Period of Time, How The Body Notices and Reacts To It, And Its Effect On The Body When Given As A Subcutaneous Injection In Patients With Multiple Sclerosis2024-513639-26-00F. Hoffmann-La Roche AG44
已完成
1 期
A Multiple-Ascending-Dose Study of MK-4318 in Healthy Participants2023-507512-12-00Merck Sharp & Dohme LLC32
招募中
1 期
A First-in-Human Dose Escalation Study of JNJ-79635322, in Participants with Relapsed or Refractory Multiple Myeloma or Previously Treated AL Amyloidosis2023-503679-12-00Janssen - Cilag International75
招募中
2 期
Efficacy and Safety of Ascending Doses of Arpraziquantel in Children Infected With Opisthorchis ViverriniNCT07262814Jennifer Keiser125
未知
1 期
NA808 PhaseI multiple ascending doses studyjRCT2080221056Chugai Pharmaceutical Co., Ltd.20